This Article Full Text Full Text (PDF) All Versions of this Article: 106/18/2385    most recent 01.CIR.0000033970.22130.93v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zobel, C. Articles by Backx, P. H. Search for Related Content PubMed PubMed Citation Articles by Zobel, C. Articles by Backx, P. H. Related Collections Hypertrophy Gene therapy Calcium cycling/excitation-contraction coupling Cell signalling/signal transduction Ion channels/membrane transport Physiological and pathological control of gene expression

(Circulation. 2002;106:2385.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Prevention of Hypertrophy by Overexpression of Kv4.2 in Cultured Neonatal Cardiomyocytes

Carsten Zobel, MD; Zameneh Kassiri, PhD; The-Tin T. Nguyen, MsC; Yang Meng, PhD; Peter H. Backx, DVM, PhD

From the Departments of Physiology and Medicine, Division of Cardiology University Health Network and Heart & Stroke Richard Lewar Centre, University of Toronto, Ontario, Canada. Dr Zobel is now at the Laboratory of Muscle Research and Molecular Cardiology, Clinic III for Internal Medicine, University of Cologne, Joseph-Stelzmann-str. 9, 50924 Cologne, Germany.

Correspondence to Peter H. Backx, DVM, PhD, Heart and Stroke/Richard Lewar Center, Fitzgerald Building, Room 68, 150 College St, Toronto, ON M5S 3E2, Canada. E-mail p.backx{at}utoronto.ca

Background— Prolonged action potentials (APs) and decreased transient outward K⁺ currents (I_to) are consistent findings in hypertrophic myocardium. However, the connection of these changes with cardiac hypertrophy is unknown. The present study investigated the effects of changes in I_to and the associated alterations in AP on myocyte hypertrophy induced by phenylephrine.

Methods and Results— Chronic incubation of cultured neonatal ventricular rat myocytes (NVRMs) with phenylephrine (PE) reduced I_to density and prolonged AP duration, leading to a 2-fold increase in the net Ca²⁺ influx per beat and a 1.4-fold increase in Ca²⁺-transient amplitude. PE treatment of chronically paced (2-Hz) NVRM also induced increases in cell size, protein/DNA ratio, atrial natriuretic factor mRNA expression, as well as ß/ myosin mRNA ratio. These hypertrophic changes were associated with a 2.4-fold increase in activation of nuclear factor of activated T-cells (NFAT), indicating increased activity of the Ca²⁺-dependent phosphatase calcineurin. Overexpression of Kv4.2 channels using adenovirus prevented the AP duration prolongation as well as the increases in Ca²⁺ influx and Ca²⁺-transient amplitude induced by PE. Kv4.2 overexpression also prohibited the PE-induced increases in cell size, protein/DNA ratio, atrial natriuretic factor expression, ß/ myosin mRNA ratio, and NFAT activation.

Conclusions— Our results demonstrate that PE-mediated hypertrophy in NRVMs seems to require I_to reductions and AP prolongation associated with increased Ca²⁺ influx and Ca²⁺ transients as well as calcineurin activation. The clinical implications of these studies and the possible involvement of other signaling pathways are discussed.

Key Words: action potentials • myocytes • ion channels • hypertrophy • calcium

This article has been cited by other articles:

				S. R. Houser and J. D. Molkentin Does Contractile Ca2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes? Sci. Signal., June 24, 2008; 1(25): pe31 - pe31. [Abstract] [Full Text] [PDF]

				K.-H. Kim, G. Y. Oudit, and P. H. Backx Erythropoietin Protects against Doxorubicin-Induced Cardiomyopathy via a Phosphatidylinositol 3-Kinase-Dependent Pathway J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 160 - 169. [Abstract] [Full Text] [PDF]

				E. Saygili, O. R. Rana, E. Saygili, H. Reuter, K. Frank, R. H. G. Schwinger, J. Muller-Ehmsen, and C. Zobel Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2898 - H2905. [Abstract] [Full Text] [PDF]

				H. Sun, B.-G. Kerfant, D. Zhao, M. G. Trivieri, G. Y. Oudit, J. M. Penninger, and P. H. Backx Insulin-Like Growth Factor-1 and PTEN Deletion Enhance Cardiac L-Type Ca2+ Currents via Increased PI3K{alpha}/PKB Signaling Circ. Res., June 9, 2006; 98(11): 1390 - 1397. [Abstract] [Full Text] [PDF]

				J. Xu, N. L. Gong, I. Bodi, B. J. Aronow, P. H. Backx, and J. D. Molkentin Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice J. Biol. Chem., April 7, 2006; 281(14): 9152 - 9162. [Abstract] [Full Text] [PDF]

				Y. Jia and K. Takimoto Mitogen-Activated Protein Kinases Control Cardiac KChIP2 Gene Expression Circ. Res., February 17, 2006; 98(3): 386 - 393. [Abstract] [Full Text] [PDF]

				W. Guo, W. E. Jung, C. Marionneau, F. Aimond, H. Xu, K. A. Yamada, T. L. Schwarz, S. Demolombe, and J. M. Nerbonne Targeted Deletion of Kv4.2 Eliminates Ito,f and Results in Electrical and Molecular Remodeling, With No Evidence of Ventricular Hypertrophy or Myocardial Dysfunction Circ. Res., December 9, 2005; 97(12): 1342 - 1350. [Abstract] [Full Text] [PDF]

				T. Volk, P. J. Noble, M. Wagner, D. Noble, and H. Ehmke Ascending aortic stenosis selectively increases action potential-induced Ca2+ influx in epicardial myocytes of the rat left ventricle Exp Physiol, January 1, 2005; 90(1): 111 - 121. [Abstract] [Full Text] [PDF]

				E. Perrier, R. Perrier, S. Richard, and J.-P. Benitah Ca2+ Controls Functional Expression of the Cardiac K+ Transient Outward Current via the Calcineurin Pathway J. Biol. Chem., September 24, 2004; 279(39): 40634 - 40639. [Abstract] [Full Text] [PDF]

				Y. Wakisaka, S. Niwano, H. Niwano, J. Saito, T. Yoshida, S. Hirasawa, H. Kawada, and T. Izumi Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure Cardiovasc Res, September 1, 2004; 63(4): 689 - 699. [Abstract] [Full Text] [PDF]